Weesp, Netherlands

Hicham Zilaout

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Solvay Pharmaceuticals, B.v.. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hicham Zilaout. Retrieved from https://idiyas.com/inventor/hicham-zilaout

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hicham Zilaout: Pioneering Technology and Innovation in Weesp, NL

Introduction: Hicham Zilaout, a dedicated inventor based in Weesp, NL, has been pushing the boundaries of what is possible through his groundbreaking inventions and collaborative efforts. His relentless pursuit of innovation has established him as a true pioneer in the world of technology.

Latest Patents: With a notable patent titled "5-aryl-4,5-dihydro-(1H)-pyrazolines as cannabinoid CB1 receptor agonists," Hicham Zilaout has showcased his expertise in pharmaceutical compositions and novel compound synthesis. This patent highlights his commitment to developing solutions for disorders involving CB1 receptors.

Career Highlights: Hicham Zilaout is a valuable asset at Solvay Pharmaceuticals B.V., where he channels his passion for innovation into tangible results. His inventive spirit has led to the creation of impactful pharmaceutical compositions, demonstrating his proficiency in the field of medicinal chemistry.

Collaborations: Collaborating closely with colleagues such as Josephus H M Lange and Bernard J Van Vliet, Hicham Zilaout has fostered a culture of creativity and excellence within the workplace. Together, they have achieved remarkable milestones and contributed significantly to the advancement of pharmaceutical research.

Conclusion: In conclusion, Hicham Zilaout's unwavering dedication to innovation and his pioneering work in developing cannabinoid CB1 receptor agonists underscore his exceptional talent and drive for impactful change in the field of technology and pharmaceuticals. He continues to inspire others with his inventive spirit and collaborative mindset, shaping a brighter future for the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…